연구성과로 돌아가기
2021 연구성과 (163 / 281)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| WoS | SCOPUS | Document Type | Document Title | Abstract | Authors | Affiliation | ResearcherID (WoS) | AuthorsID (SCOPUS) | Author Email(s) | Journal Name | JCR Abbreviation | ISSN | eISSN | Volume | Issue | WoS Edition | WoS Category | JCR Year | IF | JCR (%) | FWCI | FWCI Update Date | WoS Citation | SCOPUS Citation | Keywords (WoS) | KeywordsPlus (WoS) | Keywords (SCOPUS) | KeywordsPlus (SCOPUS) | Language | Publication Stage | Publication Year | Publication Date | DOI | JCR Link | DOI Link | WOS Link | SCOPUS Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ○ | ○ | Article | Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma | Background/Aims: Omalizumab is the first biologic known to be effective in patients with severe allergic asthma. Methods: This study was conducted as a multicenter, single-group, open trial to evaluate the improvement in the quality of life with the additional administration of omalizumab for 24 weeks in Korean patients with severe persistent allergic asthma. Results: Of the 44 patients, 31.8% were men and the mean age was 49.8 +/- 11.8 years. A score improvement of 0.5 points or more in the Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) was noted in 50.0% (22/44) of the patinets. In the improved group, the baseline total immunoglobulin E (IgE) level and the amount of omalizumab used were higher, and the day and night asthma symptoms were more severe, compared to those in the non-improved group. According to the Global Evaluation of Treatment Effectiveness, favorable outcomes were found in 78.6% of patients. The Korean asthma control test (p < 0.005) and forced expiratory volume in 1 second % predicted (FEV1%; p < 0.01) improved significantly in patients who received omalizumab treatment, compared to that at week o, and the total dose of rescue systemic corticosteroids significantly decreased (p < 0.05). The improved group on KAQLQ showed a significant improvement in FEV1% (p < 0.001). Conclusions: Omalizumab can be considered a biological treatment for Korean patients with severe allergic asthma. It is recommended to consider omalizumab as add-on therapy in patients with high baseline total IgE levels and severe asthma symptoms. | Jung, Jae-Woo; Park, Hae-Sim; Park, Choon-Sik; Cho, Sang-Heon; Choi, Inseon S.; Moon, Hee-Bom; Kwon, Soon Seog; Yoon, Ho Joo; Park, Jung Won; Lee, Jong-Myung; Choi, Dong-Chull; Choi, Byoung Whui | Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Ajou Univ, Dept Allergy & Clin Immunol, Sch Med, Suwon, South Korea; Soonchunhyang Univ, Dept Internal Med, Bucheon Hosp, Bucheon, South Korea; Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea; Univ Ulsan, Asan Med Ctr, Dept Allergy & Clin Immunol, Coll Med, Seoul, South Korea; Catholic Univ Korea, Coll Med, Dept Internal Med, Bucheon St Marys Hosp, Bucheon, South Korea; Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Allergy,Dept Med, Seoul, South Korea; Chung Ang Univ, Dept Internal Med, HCS Hyundae Hosp, 21 Bonghyeon Ro, Jinjeop Eup 12013, Namyangju, South Korea | Suh, Chang-Hee/H-9723-2019 | 57189648165; 57192203361; 7408415097; 56582804700; 7401471550; 56473736700; 55667061500; 7402990504; 8591768500; 36123106800; 8053786400; 35314596800 | bwchoimd@cau.ac.kr; | KOREAN JOURNAL OF INTERNAL MEDICINE | KOREAN J INTERN MED | 1226-3303 | 2005-6648 | 36 | 4 | SCIE | MEDICINE, GENERAL & INTERNAL | 2021 | 3.165 | 43.9 | 0.37 | 2025-07-30 | 5 | 4 | Omalizumab; Quality of life; Republic of Korea; Asthma; Prospective studies | ANTI-IGE ANTIBODY; BIOLOGICS; PREVALENCE | Asthma; Omalizumab; Prospective studies; Quality of life; Republic of Korea | Adult; Anti-Asthmatic Agents; Antibodies, Monoclonal, Humanized; Asthma; Humans; Male; Middle Aged; Omalizumab; Quality of Life; Republic of Korea; Surveys and Questionnaires; Treatment Outcome; corticosteroid; immunoglobulin E; omalizumab; antiasthmatic agent; monoclonal antibody; omalizumab; add on therapy; adult; allergic asthma; Article; Asthma Quality of Life Questionnaire; clinical trial; controlled study; disease severity; drug effect; female; forced expiratory volume; human; Korean (people); major clinical study; male; middle aged; multicenter study; prediction; prospective study; side effect; symptomatology; total quality management; treatment outcome; asthma; quality of life; questionnaire; South Korea | English | 2021 | 2021-07 | 10.3904/kjim.2020.549 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Correction | Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma (vol 36, pg 1001, 2021) | Jung, Jae-Woo; Park, Hae-Sim; Park, Choon-Sik; Cho, Sang-Heon; Choi, Inseon S.; Moon, Hee-Bom; Kwon, Soon Seog; Yoon, Ho Joo; Park, Jung Won; Lee, Jong-Myung; Choi, Dong-Chull; Choi, Byoung Whui | Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon, South Korea; Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Bucheon, South Korea; Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Allergy & Clin Immunol, Seoul, South Korea; Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Internal Med, Bucheon, South Korea; Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Allergy,Dept Med, Seoul, South Korea; Chung Ang Univ, HCS Hyundae Hosp, Dept Internal Med, Namyangju, South Korea | Suh, Chang-Hee/H-9723-2019 | 57189648165; 57192203361; 7408415097; 56582804700; 7401471550; 56473736700; 55667061500; 7402990504; 8591768500; 36123106800; 8053786400; 35314596800 | KOREAN JOURNAL OF INTERNAL MEDICINE | KOREAN J INTERN MED | 1226-3303 | 2005-6648 | 36 | 5 | SCIE | MEDICINE, GENERAL & INTERNAL | 2021 | 3.165 | 43.9 | 0 | 2025-07-30 | 0 | 0 | erratum | English | 2021 | 2021-09 | 10.3904/kjim.2020.549.e1 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||||||
| ○ | ○ | Article | Evaluation potential of PGPR to protect tomato against Fusarium wilt and promote plant growth | Soilborne fungal diseases are most common among vegetable crops and have major implications for crop yield and productivity. Eco-friendly sustainable agriculture practices that can overcome biotic and abiotic stresses are of prime importance. In this study, we evaluated the ability of plant growth-promoting rhizobacterium (PGPR) Bacillus aryabhattai strain SRB02 to control the effects of tomato wilt disease caused by Fusarium oxysporum f. sp. lycopersici (strain KACC40032) and promote plant growth. In vitro bioassays showed significant inhibition of fungal growth by SRB02. Inoculation of susceptible and tolerant tomato cultivars in the presence of SRB02 showed significant protection of the cultivar that was susceptible to infection and promotion of plant growth and biomass production in both of the cultivars. Further analysis of SRB02-treated plants revealed a significantly higher production of amino acids following infection by F. oxysporum. Analysis of plant defense hormones after inoculation by the pathogen revealed a significantly higher accumulation of salicylic acid (SA), with a concomitant reduction in jasmonic acid (JA). These results indicate that B. aryabhattai strain SRB02 reduces the effects of Fusarium wilt disease in tomato by modulating endogenous phytohormones and amino acid levels. | Nabi, Rizwana Begum Syed; Shahzad, Raheem; Tayade, Rupesh; Shahid, Muhammad; Hussain, Adil; Ali, Muhammad Waqas; Yun, Byung-Wook | Kyungpook Natl Univ, Sch Appl Biosci, Lab Plant Funct Genom, Daegu, South Korea; Rural Dev Adm, Dept Southern Area Crop Sci, Natl Inst Crop Sci, Miryang, South Korea; Univ Haripur, Dept Hort, Haripur, Pakistan; Kyungpook Natl Univ, Sch Appl Biosci, Lab Plant Breeding, Daegu, South Korea; Abdul Wali Khan Univ, Dept Agr, Mardan, Pakistan; Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England | Ali, Muhammad/V-1019-2017; Hussain, Dr. Adil/K-6016-2018; Shahzad, Raheem/AAG-8370-2019; Shahid, Muhammad/AAE-9424-2020; Tayade, Rupesh/AAM-9652-2021; Ali, Muhammad Waqas/V-1019-2017 | 57200232212; 56454250900; 57191753234; 59577718600; 41961162600; 59849025200; 8245123600 | bwyun@knu.ac.kr; | PEERJ | PEERJ | 2167-8359 | 9 | SCIE | MULTIDISCIPLINARY SCIENCES | 2021 | 3.061 | 43.9 | 2.19 | 2025-07-30 | 20 | 31 | PGPR; Bacillus aryabhattai; SRB02; Fusarium oxysporum; Tomato wilt; Tomato; Plant growth | INDUCED SYSTEMIC RESISTANCE; BACILLUS-AMYLOLIQUEFACIENS; NITRIC-OXIDE; SALINITY STRESS; BIOCONTROL; RHIZOBACTERIA; ACID; ASSOCIATION; MECHANISMS; TOLERANCE | Bacillus aryabhattai; Fusarium oxysporum; PGPR; Plant growth; SRB02; Tomato; Tomato wilt | jasmonic acid; phytohormone; salicylic acid; acclimatization; amino acid analysis; antifungal activity; Article; Bacillus; Bacillus aryabhattai; bacterial strain; bacterium; bacterium culture; biological pest control; biomass production; biotic stress; chlorophyll content; controlled study; cultivar; dry weight; flow rate; fresh weight; fungistatic activity; Fusarium oxysporum f. sp. lycopersici; Fusarium wilt; high performance liquid chromatography; infectious agent; mass fragmentography; mass spectrometry; nonhuman; plant growth; plant growth-promoting bacterium; plant height; Rhizobium; Rhizobium leguminosarum; root length; soil; solid phase extraction; symptomatology; tomato | English | 2021 | 2021-04-16 | 10.7717/peerj.11194 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020 | Helicobacter pylori infection is one of the most common infectious diseases worldwide. H. pylori is responsible for substantial gastrointestinal morbidity with a high disease burden. Since the revision of the H. pylori Clinical Practice Guidelines in 2013 in Korea, the eradication rate of H. pylori has gradually decreased with the use of a clarithromycin based triple therapy. According to a nationwide randomized controlled study by the Korean College of Helicobacter and Upper Gastrointestinal Research released in 2018, the intention-to-treat eradication rate was only 63.9%, which was mostly due to increased antimicrobial resistance to clarithromycin. The clinical practice guidelines for treatment of H. pylori were updated based on evidence-based medicine from a meta-analysis conducted on a target group receiving the latest level of eradication therapy. The draft recommendations developed based on the meta-analysis were finalized after expert consensus on three recommendations regarding the indication for treatment and eight recommendations on the treatment itself. These guidelines were designed to provide clinical evidence for the treatment of H. pylori to patients, nurses, medical school students, policymakers, and clinicians. These may differ from current medical insurance standards, and will be revised if more evidence emerges in the future. | Jung, Hye-Kyung; Kang, Seung Joo; Lee, Yong Chan; Yang, Hyo-Joon; Park, Seon-Young; Shin, Cheol Min; Kim, Sung Eun; Lim, Hyun Chul; Kim, Jie-Hyun; Nam, Su Youn; Shin, Woon Geon; Park, Jae Myung; Choi, Il Ju; Kim, Jae Gyu; Choi, Miyoung | Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; Seoul Natl Univ Hosp Healthcare, Dept Internal Med, Seoul, South Korea; Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Gastroenterol,Dept Internal Med, Seoul, South Korea; Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Gastrointestinal Canc Ctr, Seoul, South Korea; Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea; Yonsei Univ, Yongin Severance Hosp, Dept Internal Med, Coll Med, Yongin, South Korea; Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Ctr Gastr Canc, Daegu, South Korea; Hallym Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol,Seoul St Marys Hosp, Seoul, South Korea; Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Natl Evidence Based Healthcare Collaborating Agcy, Div Healthcare Technol Assessment Res, Seoul, South Korea | Kim, Jie-Hyun/Q-9061-2019; Choi, Miyoung/HZH-8501-2023; Lee, Yoojin/AAB-9799-2022; Park, Jae Myung/AGK-6655-2022; KIM, SUNG/ADF-8559-2022 | 7403029723; 51261274600; 35264717600; 57188930761; 7501833800; 35338000300; 58848142900; 36545233500; 49461401400; 55617028500; 13606883400; 8548758100; 7401471464; 34771414000; 57129603200 | leeyc@yuhs.ac; | KOREAN JOURNAL OF INTERNAL MEDICINE | KOREAN J INTERN MED | 1226-3303 | 2005-6648 | 36 | 4 | SCIE | MEDICINE, GENERAL & INTERNAL | 2021 | 3.165 | 43.9 | 1.46 | 2025-07-30 | 17 | 16 | Helicobacter pylori; Guidelines; Treatment; Meta-analysis; Microbial sensitivity tests | STANDARD TRIPLE THERAPY; PROTON-PUMP INHIBITOR; RANDOMIZED CLINICAL-TRIAL; 10-DAY SEQUENTIAL THERAPY; QUADRUPLE CONCOMITANT THERAPY; DOSE DUAL THERAPY; IRON-DEFICIENCY ANEMIA; FUNCTIONAL DYSPEPSIA; RESCUE THERAPY; BISMUTH QUADRUPLE | Guidelines; Helicobacter pylori; Meta-analysis; Microbial sensitivity tests; Treatment | Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Republic of Korea; antibiotic agent; clarithromycin; proton pump inhibitor; amoxicillin; antiinfective agent; proton pump inhibitor; antibiotic sensitivity; Article; bacterial clearance; clinician; consensus development; evidence based medicine; Helicobacter infection; Helicobacter pylori; human; medical expert; medical school; medical student; meta analysis; nonhuman; nurse; practice guideline; South Korea; systematic review; treatment indication; combination drug therapy; Helicobacter infection; Helicobacter pylori; randomized controlled trial (topic) | English | 2021 | 2021-07 | 10.3904/kjim.2020.701 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Highly sensitive updatable green hologram recording polymer with photoisomerizable azobenzene with highly birefringent acetylene as the side chain | To develop highly sensitive updatable hologram materials, an azobenzene monomer was synthesized herein that supports effective photoisomerization under visible green beam irradiation. Furthermore, an acetylene group was introduced via Sonogashira coupling for higher birefringence. Polymerization was performed on the synthesized azobenzene monomer and on the methyl methacrylate (MMA) monomer, which serves as the skeleton of the film. The structures of all molecules were characterized by nuclear magnetic resonance (NMR) spectroscopy, and UV-Visible absorption spectroscopy was performed to analyze their optical properties. The holographic writing and rewriting capabilities of the newly synthesized azobenzene side-chain polymer were characterized by using a green laser as a writing beam, which showed that a high diffraction efficiency was reliably achievable under low-energy laser irradiation when evaluated with a four-wave-mixing optical scheme. | Kang, Hye Ju; Joo, Kyung-Il; Kang, Yi Young; Lee, Jieun; Lee, Yewon; Jeon, Inhye; Lee, Tae-Hyun; Koh, Won-Gun; Choi, Jae-Hak; Kim, Hak-Rin; Ka, Jae-Won | Korea Res Inst Chem Technol, Adv Funct Polymers Res Ctr, 100 Gajeong Ro, Daejeon 34114, South Korea; Yonsei Univ, Dept Chem & Biol Engn, 50 Yonsei Ro, Seoul 03722, South Korea; Kyungpook Natl Univ, Sch Elect Engn, 80 Daehak Ro, Daegu 41566, South Korea; Kyungpook Natl Univ, Sch Elect & Elect Engn, 80 Daehak Ro, Daegu 41566, South Korea; Chungnam Natl Univ, Dept Organ Mat Engn, 99 Daehak Ro, Daejeon 34134, South Korea | Jang, Woo-Dong/I-7186-2019; Choi, Jae-Hak/D-6252-2013; Kim, Hak-Rin/T-1897-2019 | 57220867492; 36680185400; 57225861852; 57220868384; 57220874511; 57194456607; 57207924346; 7102038893; 26633472200; 7410124944; 7004309050 | rineey@knu.ac.kr;jwka@krict.re.kr; | POLYMER JOURNAL | POLYM J | 0032-3896 | 1349-0540 | 53 | 4 | SCIE | POLYMER SCIENCE | 2021 | 3.135 | 43.9 | 0.22 | 2025-07-30 | 3 | 3 | PHOTOCHROMIC DIARYLETHENE; SECURING INFORMATION; GRATINGS; STORAGE | Absorption spectroscopy; Acetylene; Acrylic monomers; Azobenzene; Birefringence; Esters; Four wave mixing; Irradiation; Lighting; Nuclear magnetic resonance; Nuclear magnetic resonance spectroscopy; Azobenzene monomers; Hologram recording; Low-energy laser irradiation; Methyl methacrylates; Nuclear magnetic resonance(NMR); Side-chain polymers; Sonogashira coupling; UV-visible absorption spectroscopy; Holograms | English | 2021 | 2021-04 | 10.1038/s41428-020-00447-x | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes | Background/Aims: Coronavirus disease 2019 (COVID-19) is a global pandemic that had affected more than 13,000 people in South Korea by July 2020. To prevent spread of COVID-19, tele-prescription was permitted temporarily. This study investigated the impact of tele-prescription on glycemic control in patients with type 2 diabetes. Methods: Glycated hemoglobin (HbA1c) concentrations were retrospectively analyzed in patients with type 2 diabetes who were treated with tele-prescription because of COVID-19 and those who were treated by face-to-face care (non-tele-prescription group) enrolled at the same period of time. Mean HbA1c concentrations and mean change in HbA1c concentration (Delta HbA1c) were compared in these two groups. Results: The mean HbA1c levels of patients were significantly higher after than before the tele-prescription period (7.46% +/- 1.24% vs. 7.27% +/- 1.13%, p < 0.05). Mean Delta HbA1c was significantly higher in the tele-prescription than in the non-tele-prescription group (0.19% +/- 0.68% vs. 0.04% +/- 0.95%, p < 0.05). HbA1c was significantly greater in patients taking fewer oral hypoglycemic agents, no insulin, fewer comorbidities (e.g., coronary artery disease, cerebrovascular accident, and diabetic neuropathy), and higher baseline HbA1c. Conclusions: Tele-prescription may worsen glycemic control in patients with type 2 diabetes during public health crises. | Park, Sung-Don; Kim, Na-Young; Jeon, Jae-Han; Kim, Jung-Guk; Lee, In-Kyu; Park, Keun-Gyu; Choi, Yeon-Kyung | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Internal Med, Korea, South Korea | 57222220058; 57201292256; 36910340400; 16506485900; 36071537600; 57202558343; 35335932600 | ykchoi@knu.ac.kr; | KOREAN JOURNAL OF INTERNAL MEDICINE | KOREAN J INTERN MED | 1226-3303 | 2005-6648 | 36 | 4 | SCIE | MEDICINE, GENERAL & INTERNAL | 2021 | 3.165 | 43.9 | 0.46 | 2025-07-30 | 4 | 5 | COVID-19; Tele-prescription; Glycated hemoglobin A; Diabetes mellitus; type 2 | TELEMEDICINE; SEVERITY | COVID-19; Diabetes mellitus, type 2; Glycated hemoglobin A; Tele-prescription | Blood Glucose; COVID-19; Diabetes Mellitus, Type 2; Glycated Hemoglobin A; Glycemic Control; Humans; Hypoglycemic Agents; Prescriptions; Republic of Korea; Retrospective Studies; SARS-CoV-2; antidiabetic agent; glycosylated hemoglobin; glucose blood level; glycemic control; human; non insulin dependent diabetes mellitus; prescription; retrospective study; South Korea | English | 2021 | 2021-07 | 10.3904/kjim.2020.464 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | Article | Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea | Background/Aims: We examined the concordance rate among fasting plasma glucose (FPG), 2-hour post-challenge glucose (2hr PG), and hemoglobin A1c (HbA1c) in the diagnosis of diabetes in a population with a high-risk for type 2 diabetes mellitus (T2DM) in Korea. Methods: Among the participants from the Korean Diabetes Prevention Study, individuals with FPG ≥ 100 mg/dL, body mass index (BMI) ≥ 23.0 kg/m2, and no previous history of T2DM were consecutively enrolled after a 75 g glucose tolerance test. We analyzed the differences in the clinical characteristics in subjects with stage 1 (FPG, 100 to 109 mg/dL) and stage 2 (FPG, 110 to 125 mg/dL) impaired fasting glucose (IFG). Results: Of 1,637 participants, 27.2% had T2DM and 59.3% had IFG and/or impaired glucose tolerance (IGT). The mean age was 55.0 ± 8.1 years and the mean BMI was 26.3 ± 2.7 kg/m2. Based on FPG criteria, 515 (31.4%) and 352 (21.5%) subjects were classified as having stage 1 and stage 2 IFG, respectively. The 19.0% of stage 1 and 43.5% of stage 2 subjects showed 2hr PG levels in the diabetic range. Even for those in the normal FPG range, 63 (9.5%) participants showed a 2hr PG level of ≥ 200 mg/dL. Of 446 subjects with newly-diagnosed diabetes, 340 (76.2%) showed FPG levels <; 126 mg/dL. Conclusions: The oral glucose tolerance test should be actively considered for Korean adults who are overweight or obese with the IFG range (FPG, 100 to 125 mg/dL) to allow for early detection of diabetes and prompt intervention. © 2021 The Korean Association of Internal Medicine. | Lee, Jin-Hee; Chon, Suk; Cha, Seon-Ah; Lim, Sun-Young; Kim, Kook-Rye; Yun, Jae-Seung; Rhee, Sang Youl; Yoon, Kun-Ho; Ahn, Yu-Bae; Woo, Jeong-Taek; Ko, Seung-Hyun; Lee, Moon-Kyu; Park, Kyong Soo; Cha, Bong Soo; Baik, Sei-Hyun; Park, Joong Yeol; Lee, Kwan Woo; Lee, In-Kyu; Park, Tae Sun; Kim, In Joo; Cho, Young Jung; Cho, Dong Hyeok; Chun, Sung Wan; Kim, So Hun; Sohn, Seo Young; Hwang, You Cheol; Kang, Eunjeong; Choi, Jihye | Catholic Institute of Smart Healthcare Center, Institute of Biomedical Industry, The Catholic University of Korea, Seoul, South Korea; Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, South Korea; Catholic Institute of Smart Healthcare Center, Institute of Biomedical Industry, The Catholic University of Korea, Seoul, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, South Korea; Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, South Korea; Catholic Institute of Smart Healthcare Center, Institute of Biomedical Industry, The Catholic University of Korea, Seoul, South Korea, Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, South Korea; Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, South Korea; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Medical Center, Korea University College of Medicine, Seoul, South Korea; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea; Department of Internal Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, South Korea; Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, South Korea; Department of Internal Medicine, National Medical Center, Seoul, South Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea; Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, South Korea; Department of Internal Medicine, Inha University School of Medicine, Incheon, South Korea; Division of Endocrinology, Department of Medicine, Myongji Hospital, Goyang, South Korea; Department of Endocrinology and Metabolism, Kyung-Hee University Hospital at Gangdong, Kyung-Hee University School of Medicine, Seoul, South Korea; Department of Endocrinology and Metabolism, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, South Korea; Department of Endocrinology and Metabolism, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, South Korea | 57208649770; 8339069800; 56768814100; 7404080785; 57194171231; 55295353700; 8606892300; 7401607578; 8713892300; 9335759500; 7403325370; 7409120503; 35243240300; 7007118478; 7102833918; 10140804200; 57209515318; 36071537600; 56697789200; 36044896200; 57092859700; 59603592600; 24075302300; 56499561100; 36007700000; 23670001600; 58826745100; 57303237700 | kosh@catholic.ac.kr; | Korean Journal of Internal Medicine | KOREAN J INTERN MED | 1226-3303 | 2005-6648 | 36 | 2 | SCIE | MEDICINE, GENERAL & INTERNAL | 2021 | 3.165 | 43.9 | 0.27 | 2025-07-30 | 3 | Diabetes mellitus; Hemoglobin A1C; Impaired fasting glucose; Overweight; Prediabetic state; Type 2 | Adult; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Humans; Middle Aged; Obesity; Overweight; Republic of Korea; glucose; hemoglobin A1c; adult; Article; body mass; disease classification; female; glucose tolerance test; groups by age; hemoglobin blood level; high risk population; human; impaired glucose tolerance; Korea; major clinical study; male; mass screening; middle aged; non insulin dependent diabetes mellitus; obesity; complication; diet restriction; glucose blood level; non insulin dependent diabetes mellitus; obesity; South Korea | English | Final | 2021 | 10.3904/kjim.2019.171 | 바로가기 | 바로가기 | 바로가기 | |||||||
| ○ | ○ | Editorial Material | Invited Response on: "Usefulness of Incisional Negative Pressure Wound Therapy for Decreasing Wound Complication Rates and Seroma Formation Following Prepectoral Breast Reconstruction" | Ryu, Jeong Yeop; Yang, Jung Dug | Kyungpook Natl Univ, Sch Med, Dept Plast & Reconstruct Surg, 130 Dongdeok Ro, Daegu 41944, South Korea | Yang, Jung/R-7806-2019; Ryu, Jeong Yeop/GLQ-9419-2022 | 56366349400; 55171704700 | lambyang@knu.ac.kr; | AESTHETIC PLASTIC SURGERY | AESTHET PLAST SURG | 0364-216X | 1432-5241 | 45 | 4 | SCIE | SURGERY | 2021 | 2.708 | 43.9 | 0.85 | 2025-07-30 | 1 | 1 | Breast Implantation; Humans; Mammaplasty; Negative-Pressure Wound Therapy; Seroma; adverse event; breast augmentation; breast reconstruction; human; seroma; vacuum assisted closure | English | 2021 | 2021-08 | 10.1007/s00266-021-02202-w | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||||
| ○ | ○ | Article | Pediatric-inspired regimen with late intensifi- cation and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study | Background/Aims: The objective of this study was to evaluate the efficacy and feasibility of the pediatric-inspired regimen of the adult acute lymphoblastic leukemia (ALL) Working Party, the Korean Society of Hematology. Methods: Data of 99 patients with newly diagnosed ALL, who were treated with the KALLA 1406/1407 protocol, were retrospectively analyzed. All patients equally received age-adjusted daunorubicin, vincristine, and prednisolone. L-asparaginase was additionally administered to Philadelphia (Ph)-negative patients according to age, whereas Ph-positive patients received 600 mg/day of imatinib. Results: A total of 99 patients were enrolled in this study, of whom 62 (62.6%) were diagnosed with Ph-negative ALL and 37 (37.3%) were diagnosed with Ph -positive ALL. The median age of patients in the Ph-negative ALL group was 46 years, and that of patients in the Ph-positive ALL group was 49 years. In patients with Ph-negative ALL, 57 (92%) patients achieved complete remission (CR) and CR with incomplete hematologic recovery (CRi). Disease-free survival (DFS) and overall survival (OS) rates at 2 years were estimated to be 42% and 63%, respectively. In patients with Ph-positive ALL, 32 (86%) patients achieved CR/CRi, and 2-year DFS and OS were 31.2% and 49.1%, respectively. Patients who were able to proceed to the allogeneic hematopoietic cell transplantation and younger patients showed significantly superior survival in both Ph-negative ALL and Ph-positive ALL. Neutropenic fever and bacterial infection were the most common and severe adverse events. Conclusions: The KALLA 1406/1407 protocol showed tolerable toxicities in adult ALL patients. Especially, younger patients had more survival benefits with KALLA 1406/1407 protocol. | Baek, Dong Won; Kim, Dae Young; Sohn, Sang Kyun; Koh, Youngil; Jung, Sung-Hoon; Yhim, Ho-Young; Choi, Yunsuk; Moon, Joon Ho | Kyungpook Natl Univ Hosp, Dept Hematol Oncol, Daegu, South Korea; Ewha Womans Univ, Sch Med, Dept Hematol & Oncol, Seoul, South Korea; Seoul Natl Univ Hosp, Dept Hematol Oncol, Seoul, South Korea; Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Hwasun, South Korea; Jeonbuk Natl Univ Hosp, Dept Hematol Oncol, Jeonju, South Korea; Ulsan Univ Hosp, Dept Hematol Oncol, Ulsan, South Korea | ; Yhim, Ho-Young/J-1531-2012 | 57191874272; 59616717300; 13310226800; 56450114900; 55511978300; 35785270600; 35200292800; 56568642700 | jhmoon@knu.ac.kr; | KOREAN JOURNAL OF INTERNAL MEDICINE | KOREAN J INTERN MED | 1226-3303 | 2005-6648 | 36 | 6 | SCIE | MEDICINE, GENERAL & INTERNAL | 2021 | 3.165 | 43.9 | 0.46 | 2025-07-30 | 5 | 6 | Precursor cell lymphoblastic leukemia-lymphoma; Drug therapy; As-paraginase; Stem cell transplantation | TERM-FOLLOW-UP; HYPER-CVAD; IMPROVES SURVIVAL; YOUNG-ADULTS; CHILDREN; THERAPY; RISK; DEXAMETHASONE; ADOLESCENTS; CANCER | As-paraginase; Drug therapy; Precursor cell lymphoblastic leukemia-lymphoma; Stem cell transplantation | Asparaginase; Humans; Imatinib Mesylate; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; asparaginase; creatinine; cyclophosphamide; cytarabine; daunorubicin; dexamethasone; imatinib; mercaptopurine; methotrexate; prednisolone; vincristine; asparaginase; imatinib; acute lymphoblastic leukemia; adolescent; adult; aged; allogeneic hematopoietic stem cell transplantation; Article; bacterial infection; bleeding; cancer survival; clinical protocol; constipation; controlled study; creatinine blood level; cytogenetics; cytopenia; diarrhea; disease free survival; disseminated intravascular clotting; drug dose increase; drug efficacy; drug safety; drug tolerability; echocardiography; febrile neutropenia; female; heart disease; heart ejection fraction; human; ileus; informed consent; kidney disease; kidney function; major clinical study; male; middle aged; mycosis; nausea; onset age; overall survival; pancreatitis; peripheral neuropathy; rash; retrospective study; virus infection; vomiting; acute lymphoblastic leukemia; Philadelphia 1 chromosome | English | 2021 | 2021-11 | 10.3904/kjim.2021.028 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | The Korean Hypertension Cohort study: design and baseline characteristics | Background/Aims: Hypertension (HT) has a significant impact on public health and medical expenses. However, HT is a chronic disease that requires the long-term follow-up of a large number of patients. Methods: The Korean Hypertension Cohort (KHC) study aimed to develop a model for calculating cardiovascular risk in HT patients by linking and utilizing the detailed clinical and longitudinal data from hospitals and the national health insurance claim database, respectively. This cohort had a planned sample size of over 11,000 HT patients and 100,000 non-HT controls. Eligible patients were hypertensive patients, who were presenting for the first time and were diagnosed with HT as a main disease from 2006 to 2011. Long-term survival data over a period of approximately 9 years were obtained from the national health insurance claim and national health examination data. Results: This cohort enrolled 11,083 patients with HT. The mean age was 58.87 +/- 11.5 years, 50.5% were male, and 31.4% were never-treated HT. Of the enrolled patients, 32.9% and 37.7% belonged to the high and moderate cardiovascular risk groups, respectively. Initial blood pressures were 149.4 +/- 18.5/88.5 +/- 12.5 mmHg. During the 2 years hospital data follow-up period, blood pressures lowered to 130.8 +/- 14.1/78.0 +/- 9.7 mmHg with 1.9 +/- 1.0 tablet doses of antihypertensive medication. Cardiovascular events occurred in 7.5% of the overall patients; 8.5%, 8.8%, and 4.7% in the high, moderate, and low risk patients, respectively. Conclusions: The KHC study has provided important information on the long-term outcomes of HT patients according to the blood pressure, comorbid diseases, medication, and adherence, as well as health behaviors and health resource use. | Lee, Hae-Young; Lee, Ju-Yeon; Shin, Ho-Gyun; Cho, Song-Hee; Park, Kyun-Ik; Oh, Gyu-Chul; Lee, Seung-Pyo; Kim, Hogon; Lee, Hee-Sun; Kim, Kwang-Il; Kang, Si-Hyuck; Lee, Jang Hoon; Jang, Se Yong; Lee, Ju-Hee; Kim, Kye Hun; Cho, Jae Yeong; Park, Jae-Hyeong; Jang, Jieun; Park, Sue K.; Bak, Jean Kyung | Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; Seoul Natl Univ, Coll Pharm, Seoul, South Korea; Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea; Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Sungnam, South Korea; Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea; Chungbuk Natl Univ Hosp, Div Cardiol, Dept Internal Med, Cheongju, South Korea; Chonnam Natl Univ Hosp, Dept Cardiovasc Med, Gwangju, South Korea; Chungnam Natl Univ, Dept Internal Med, Coll Med, Daejeon, South Korea; Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea | Kang, Si-Hyuck/AAR-9790-2020; Oh, Gyu/AAJ-6530-2021; Kim, Kwang-il/D-8024-2012; Cho, Jae Yeong/GVT-2986-2022; Park, Jae-Hyeong/AAD-9015-2021; Lee, Jung-Seok/L-6826-2019; LEE, Seung/ISA-9627-2023; Lee, Hye-Young/JEP-8044-2023; Kim, Kwang-il/AAP-7315-2021 | 56151235500; 57964833500; 57219900089; 57204035564; 57277120600; 52264473100; 55665415400; 57225125180; 55548996000; 57193847032; 35740757100; 54581258000; 57207977889; 57204073070; 56150430800; 23024350000; 36063048400; 57198251721; 8085325400; 57277449200 | hylee612@snu.ac.kr; | KOREAN JOURNAL OF INTERNAL MEDICINE | KOREAN J INTERN MED | 1226-3303 | 2005-6648 | 36 | 5 | SCIE | MEDICINE, GENERAL & INTERNAL | 2021 | 3.165 | 43.9 | 0.82 | 2025-07-30 | 8 | 9 | Hypertension; Cohort | BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MANAGEMENT; GUIDELINES; SOCIETY | Cohort; Hypertension | Aged; Antihypertensive Agents; Blood Pressure; Cohort Studies; Humans; Hypertension; Male; Middle Aged; Republic of Korea; acetylsalicylic acid; aldosterone antagonist; alpha adrenergic receptor blocking agent; angiotensin receptor antagonist; antidiabetic agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; hydroxymethylglutaryl coenzyme A reductase inhibitor; thiazide diuretic agent; antihypertensive agent; adult; aged; aging; Article; blood pressure measurement; cardiovascular risk; clinical study; cohort analysis; comorbidity; controlled study; female; follow up; health behavior; health care planning; high risk patient; human; hypertension; long term survival; longitudinal study; low risk patient; major clinical study; male; medical examination; national health insurance; observational study; patient compliance; sample size; sex ratio; South Korea; blood pressure; hypertension; middle aged | English | 2021 | 2021-09 | 10.3904/kjim.2020.551 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | The Usefulness of Endoscopic Harvesting of the Latissimus Dorsi Flap for Breast Reconstruction Using a Single-Port and CO2 Gas Insufflation Technique | Background In the recent trend toward less aggressive approaches to breast reconstruction, minimally invasive harvesting of the latissimus dorsi (LD) flaps has long been a desirable goal. Endoscopically-assisted LD flap harvesting was reported as a method for minimizing scar formation and reducing donor-site morbidity. This study investigates the surgical outcomes of endoscopically-assisted immediate breast reconstruction with LD muscle flaps. Materials and Methods This prospective study included 21 patients who underwent endoscopically-assisted breast reconstruction with LD muscle flap and 20 patients who underwent breast reconstruction with conventional harvesting LD musculocutaneous flap. In patients with nonexcised skin or possible primary closure, the reconstruction was performed with endoscopically-assisted LD muscle flaps using the single-port and CO2 gas insufflation technique. The patients were classified into groups according to the location of the defect and mastectomy type. Moreover, patient satisfaction was investigated 6 months after surgery. Results In patients who underwent endoscopically-assisted breast reconstruction with LD muscle flaps, the scar of the donor-site was vertical, and the size was 4 cm to be obscured when lowering the arms. In comparison with patients who underwent breast reconstruction with conventional LD flaps, those who underwent endoscopically-assisted breast reconstruction with LD muscle flaps showed shorter hospital stay and no difference in patient satisfaction. Conclusion Endoscopically-assisted breast reconstruction with LD flaps showed no difference in patient satisfaction with good esthetic results compared with conventional LD flaps. The endoscopic LD muscle flap harvest technique using a single-port and CO2 insufflation technique can be very useful in breast reconstruction that does not require a skin paddle. | Kim, Do Gon; Kim, Jong Seong; Lee, Joon Seok; Lee, Jeeyeon; Park, Ho Yong; Yang, Jung Dug | Kyungpook Natl Univ, Sch Med, Dept Plast & Reconstruct Surg, 130 Dongdeokro, Daegu 41944, South Korea; Kyungpook Natl Univ, Sch Med, Dept Surg, Daegu, South Korea | PARK, JUN-YOUNG/P-5981-2015; Yang, Jung/R-7806-2019; Lee, Jong-Mok/KVY-9550-2024; LEE, JIN/Q-3108-2018 | 57208642340; 57210152149; 56496041000; 37079213100; 56564377200; 55171704700 | lambyang@knu.ac.kr; | AESTHETIC PLASTIC SURGERY | AESTHET PLAST SURG | 0364-216X | 1432-5241 | 45 | 6 | SCIE | SURGERY | 2021 | 2.708 | 43.9 | 0.66 | 2025-07-30 | 5 | 4 | Endoscopic harvesting; Latissimus dorsi flap; Breast reconstruction; Oncoplastic surgery; CO2 insufflation technique; Single-port technique | NIPPLE-SPARING MASTECTOMY; CLINICAL-EXPERIENCE; FEASIBILITY; SURGERY | Breast reconstruction; CO<sub>2</sub> insufflation technique; Endoscopic harvesting; Latissimus dorsi flap; Oncoplastic surgery; Single-port technique | Breast Neoplasms; Carbon Dioxide; Female; Humans; Insufflation; Mammaplasty; Mastectomy; Prospective Studies; Superficial Back Muscles; Treatment Outcome; carbon dioxide; aeration; back muscle; breast reconstruction; breast tumor; female; human; mastectomy; prospective study; treatment outcome | English | 2021 | 2021-12 | 10.1007/s00266-021-02467-1 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | A Cyber-Physical System and Graph-Based Approach for Transportation Management in Smart Cities | In the last decade, technological advancements in the cyber-physical system have set the basis for real-time and context-aware services to ease human lives. The citizens, especially travelers, want to experience a safe, healthy, and timely journey to their destination. Smart and on-ground real-time traffic analysis helps authorities further improve decision-making to ensure safe and convenient traveling. In this paper, we proposed a transport-control model that exploits cyber-physical systems (CPS) and sensor-technology to continuously monitor and mine the big city data for smart decision-making. The system makes use of travel-time, traffic intensity, vehicle's speed, and current road conditions to construct a weighted city graph representing the road network. Traditional graph algorithms with efficient implementation technologies are employed to respond to commuters' and authorities' needs in order to achieve a smart and optimum transportation system. To efficiently process the incoming big data streams, the proposed architecture uses the Apache GraphX tool with several parallel processing nodes, along with Spark and Hadoop that ultimately provide better performance against various state-of-the-art solutions. The system is thoroughly evaluated in terms of system throughput and processing time, revealing that the proposed system is efficient, robust, and scalable. | Rathore, Muhammad Mazhar; Attique Shah, Syed; Awad, Ahmed; Shukla, Dhirendra; Vimal, Shanmuganathan; Paul, Anand | Hamad Bin Khalifa Univ, Coll Sci & Engn, Div Informat & Comp Technol, Doha, Qatar; Univ Tartu, Inst Comp Sci, Data Syst Grp, EE-51005 Tartu, Estonia; Cairo Univ, Fac Comp & Artificial Intelligence, Giza 12613, Egypt; Univ New Brunswick, J Herbert Smith Ctr, Fredericton, NB NB E3B, Canada; Ramco Inst Technol, Comp Sci & Engn Dept, Rajapalayam 626117, India; Kyungpook Natl Univ, Sch Comp Sci & Engn, Daegu 41566, South Korea | Paul, Anand/V-6724-2017; Awad, Ahmed/C-8350-2018; Shah, Syed Attique/ABD-6564-2021; SHANMUGANATHAN, VIMAL/E-9551-2016 | 56650727000; 57194554620; 57189881011; 57202226465; 57150956300; 56650522400 | mrathore@hbku.edu.qa;syed.shah@ut.ee;ahmed.awad@ut.ee;dshukla@unb.ca;svimalphd@gmail.com;paul.editor@gmail.com; | SUSTAINABILITY | SUSTAINABILITY-BASEL | 2071-1050 | 13 | 14 | SCIE;SSCI | ENVIRONMENTAL SCIENCES;ENVIRONMENTAL STUDIES;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY | 2021 | 3.889 | 44.1 | 1.91 | 2025-07-30 | 26 | 36 | cyber-physical system; smart transportation; big data; smart city; stream analysis | BIG DATA ANALYTICS; PERFORMANCE; PREDICTION; FRAMEWORK; INTERNET; DESIGN | Big data; Cyber-physical system; Smart city; Smart transportation; Stream analysis | Varanidae; decision making; management practice; smart city; spatiotemporal analysis; transportation planning; transportation system | English | 2021 | 2021-07 | 10.3390/su13147606 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | A Secure, Lightweight, and Anonymous User Authentication Protocol for IoT Environments | The Internet of Things (IoT) is being applied to various environments such as telecare systems, smart homes, and intelligent transportation systems. The information generated from IoT devices is stored at remote servers, and external users authenticate to the server for requesting access to the stored data. In IoT environments, the authentication process is required to be conducted efficiently, and should be secure against various attacks and ensure user anonymity and untraceability to ensure sustainability of the network. However, many existing protocols proposed in IoT environments do not meet these requirements. Recently, Rajaram et al. proposed a paring-based user authentication scheme. We found that the Rajaram et al. scheme is vulnerable to various attacks such as offline password guessing, impersonation, privileged insider, and known session-specific temporary information attacks. Additionally, as their scheme uses bilinear pairing, it requires high computation and communication costs. In this study, we propose a novel authentication scheme that resolves these security problems. The proposed scheme uses only hash and exclusive-or operations to be applicable in IoT environments. We analyze the proposed protocol using informal analysis and formal analysis methods such as the BAN logic, real-or-random (ROR) model, and the AVISPA simulation, and we show that the proposed protocol has better security and performance compared with existing authentication protocols. Consequently, the proposed protocol is sustainable and suitable for real IoT environments. | Son, Seunghwan; Park, Yohan; Park, Youngho | Kyungpook Natl Univ, Sch Elect & Elect Engn, Daegu 41566, South Korea; Keimyung Univ, Sch Comp Engn, Daegu 42601, South Korea; Kyungpook Natl Univ, Sch Elect Engn, Daegu 41566, South Korea | 57221744477; 55660095600; 56962990300 | sonshawn@knu.ac.kr;yhpark@kmu.ac.kr;parkyh@knu.ac.kr; | SUSTAINABILITY | SUSTAINABILITY-BASEL | 2071-1050 | 13 | 16 | SCIE;SSCI | ENVIRONMENTAL SCIENCES;ENVIRONMENTAL STUDIES;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY | 2021 | 3.889 | 44.1 | 1.91 | 2025-07-30 | 27 | 32 | mutual authentication; key agreement; lightweight; anonymity; IoT environment; BAN logic; ROR model; AVISPA simulation | KEY AGREEMENT PROTOCOL; PROVABLY SECURE; ACCESS-CONTROL; SCHEME; INTERNET; DESIGN; EXCHANGE; DRONES | Anonymity; AVISPA simulation; BAN logic; IoT environment; Key agreement; Lightweight; Mutual authentication; ROR model | Internet; numerical model; performance assessment; simulation; sustainability; transportation; vulnerability | English | 2021 | 2021-08 | 10.3390/su13169241 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | A Study on the Millennials Usage Behavior of Social Network Services: Effects of Motivation, Density, and Centrality on Continuous Intention to Use | Whether in terms of social media platforms, mobile pay apps or an increasing acceptance of RFID chips in humans, technology has transformed everyday life for consumers. Social networks have experienced enormous growth as online personal networking media. Social exchange theory (for motivation and social reward) and theories of collective action can be applied in order to understand how an individual's behavior may exert effects on or receive influences from other users with regard to the continuance usage intention of social apps. First, this study aims to examine behavioral characteristics of the Millennials, and takes flow and social reward systematically so as to explore SNS users' continuance based on SNS characteristics. Targeting Millennials SNS users, this study empirically examines users' continuance intention at individual level and simulates users' continuance behavior at group level, which are expected to be influential as a next generation of purchasing group, focusing on social network services (SNS) usage. Second, this study tries to suggest strategic implications by identifying key factors that dominate SNS users' behavior in the process of experiencing SNS. For the empirical purpose, this study analyzes the relationship between SNS characteristics (motivation to use, density, and centrality) and usage behavior (flow, social reward, and continuous intention to use). As a result, each construct of motivation to use SNS, SNS density, and SNS centrality are positively linked with flow. Motivation to use SNS and SNS centrality are positively associated with social reward, however, SNS density does not have a significant effect on social reward. In addition, flow and social reward turn out to have positive linkage with continuous intention to use respectively. The findings of this study are expected to provide implications for researchers and operators in related fields to identify various factors that explain the SNS usages of the Millennials, especially the major factors that sustain SNS involvement and activities. This study can enrich both SNS continuance theory, and help SNS operators to manipulate resources effectively to attract and retain users. | Park, Gwijeong; Chen, Fangxin; Cheng, Le | Kyungpook Natl Univ, Off Res & Ind Univ Cooperat, Daegu 41566, South Korea; Zhejiang Univ, Sch Int Studies, Hangzhou 310058, Peoples R China | 57200142014; 57222368472; 26038082200 | id1031@knu.ac.kr;chenfangxin@hanmail.net;chengle163@hotmail.com; | SUSTAINABILITY | SUSTAINABILITY-BASEL | 2071-1050 | 13 | 5 | SCIE;SSCI | ENVIRONMENTAL SCIENCES;ENVIRONMENTAL STUDIES;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY | 2021 | 3.889 | 44.1 | 2.05 | 2025-07-30 | 27 | 33 | millennials; social network services; motivation; density; centrality; flow; social reward; continuous intention to use | OPTIMAL EXPERIENCE; FLOW EXPERIENCE; MOBILE; SITES; SNS | Centrality; Continuous intention to use; Density; Flow; Millennials; Motivation; Social network services; Social reward | collective action; perception; resource use; social media; strategic approach | English | 2021 | 2021-03 | 10.3390/su13052680 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Aspergillus foetidus Regulated the Biochemical Characteristics of Soybean and Sunflower under Heat Stress Condition: Role in Sustainability | Plants are susceptible to various environmental constrains, including heat stress due to their sessile nature. Endophytic fungi can be used as a novel technique to protect crop plants against the injurious effects of thermal stress. Endophytic fungi were isolated from Adiantum capillus-veneris L. and tested against heat stress in Glycine max L. and Helianthus annuus L. The results exhibited increased levels of the plant's chlorophyll, height and biomass in Aspergillus foetidus (AdR-13) inoculated host crop species. Conversely, a significant decrease in lipid peroxidation and reactive oxygen species (ROS) production was noted in A. foetidus-associated host crop species. Likewise, the amounts of ROS-degrading antioxidants (glutathione reductase (GR), peroxidase (POD), ascorbic acid oxidase (AAO), superoxide dismutase (SOD), catalase (CAT)) as well as phenolics were increased, while the amounts of proline and abscisic acid (ABA) were decreased in fungal-associated test crops. Total lipids, proteins and sugars were noted to be high in A. foetidus-associated test crops. From the results, we concluded that A. foetidus have a role in heat stress mitigation that might help to sustain the production of important crops in the future. | Ismail; Hamayun, Muhammad; Hussain, Anwar; Iqbal, Amjad; Khan, Sumera Afzal; Ahmad, Ayaz; Gul, Sarah; Kim, Ho-Youn; Lee, In-Jung | Abdul Wali Khan Univ Mardan, Dept Bot, Mardan 23200, Pakistan; Abdul Wali Khan Univ Mardan, Dept Food Sci & Technol, Mardan 23200, Pakistan; Univ Peshawar, Ctr Biotechnol & Microbiol, Peshawar 25000, Pakistan; Abdul Wali Khan Univ Mardan, Dept Biotechnol, Mardan 23200, Pakistan; Int Islamic Univ, Fac Basic & Appl Sci, Dept Biol Sci, Islamabad 1243, Pakistan; Korea Inst Sci & Technol KIST, Smart Farm Res Ctr, Gangwon 25451, South Korea; Kyungpook Natl Univ, Dept Appl Biosci, Daegu 41566, South Korea | ; Iqbal, Amjad/E-2010-2014; Ayaz, Ahmad/GVT-1025-2022; Hamayun, Muhammad/B-1694-2010; Khan, Abdul/H-5910-2011; Ahmad, Ayaz/GVT-1025-2022; Lee, In-Jung/GLS-0432-2022; Hussain, Anwar/N-1605-2019; Kim, Soo/P-7880-2016 | 57205183198; 59297330100; 35621772200; 10142205100; 9636646900; 55420263200; 57216951757; 57191717301; 16425830900 | ismail160@yahoo.com;hamayun@awkum.edu.pk;drhussain@awkum.edu.pk;amjadiqbal@awkum.edu.pk;drsumera@uop.edu.pk;ahdayazb5@awkum.edu.pk;sarah.gul@iiu.edu.pk;hykim@kist.re.kr;ijlee@knu.ac.kr; | SUSTAINABILITY | SUSTAINABILITY-BASEL | 2071-1050 | 13 | 13 | SCIE;SSCI | ENVIRONMENTAL SCIENCES;ENVIRONMENTAL STUDIES;GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY | 2021 | 3.889 | 44.1 | 0.78 | 2025-07-30 | 10 | 13 | endophytic fungi; A; foetidus; Adiantum capillus-veneris L; heat stress; antioxidants; ROS | RAPID-DETERMINATION; SALINITY TOLERANCE; PROLINE; GROWTH; PERFORMANCE; PLANTS; ACID; ACCUMULATION; GLUTATHIONE; CATALASE | A. foetidus; Adiantum capillus-veneris L; Antioxidants; Endophytic fungi; Heat stress; ROS | Adiantum capillus-veneris; Aspergillus foetidus; Glycine max; Helianthus; Helianthus annuus; abscisic acid; ascorbic acid; biomass; endophyte; environmental factor; enzyme; enzyme activity; fungus; lipid; reactive oxygen species; sessile species; sustainability; temperature effect | English | 2021 | 2021-07 | 10.3390/su13137159 | 바로가기 | 바로가기 | 바로가기 | 바로가기 |
페이지 이동: